Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry.

ABSTRACT:

Aims

The prevalence of advanced heart failure (HF) is increasing due to the growing number of patients with HF and their better treatment and survival. There is a scarcity of data on the accuracy of HF web-based risk scores in this selected population. This study aimed to assess mortality prediction performance of the Meta-Analysis Global Group in Chronic HF (MAGGIC-HF) risk score and the model of the Barcelona Bio-HF Risk Calculator (BCN-Bio-HF) containing N terminal pro brain natriuretic peptide in HF patients receiving intermittent inotropic support with levosimendan as destination therapy.

Methods and results

Four hundred and three advanced HF patients from 23 tertiary hospitals in Spain receiving intermittent inotropic support with levosimendan as destination therapy we

SUBMITTER: Codina P 

PROVIDER: S-EPMC10567651 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature